Gastrointestinal decontamination.
Overall, no conclusive data support the use of gastric decontamination in the routine management of the poisoned patient. Studies of asymptomatic patients suggest that no treatment is required, and, given the complications that have been reported, this may be a reasonable approach to' most patients. Even in symptomatic patients, the only demonstrable benefit was found in a post-hoc subgroup analysis and involved an outcome of questionable clinical importance. Given these data, it would be easy to conclude that GI decontamination has no role in the management of the poisoned patient. This conclusion is valid when considering poisoned patients as a group, but all poisoned patients are not the same. Patients with trivial ingestion do well without treatment, and their greatest risk is an iatrogenic complication. Even patients with more serious ingestions usually have good outcomes with supportive care alone. It is no longer sufficient to justify GL or forced administration of AC with the supposition that "the patient could have taken something bad." However,there are some overdoses where limiting the systemic absorption of the poison may limit the toxic effects and prevent serious toxicity. After careful consideration of the risks, GI decontamination should be targeted at patients who, in the opinion of the treating physician, have a potentially life-threatening exposure.
Heard
Kennon
K
Division of Emergency Medicine, University of Colorado School of Medicine, Denver, CO 80262, USA. kennon.heard@uchsc.edu
D002606:Charcoal / Q000008:administration & dosage; D004639:Emetics / Q000008:administration & dosage; D005751:Gastric Lavage / Q000379:methods*; D006801:Humans; D007486:Ipecac / Q000008:administration & dosage; D011041:Poisoning / Q000628:therapy
D004639:Emetics; D002606:Charcoal; D007486:Ipecac